|
UCART20x22 Clinical Trials
1 actively recruiting trial across 1 location
Chicago, Illinois1 trial
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
The University of Chicago Medical Center (UCMC)
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.